Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 1476 | 60 | 1.3905 | 1.3028 | 0.0407 | 0.0415 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 818 | 40 | 0.7640 | 0.6789 | 0.0489 | 0.0471 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 737 | 35 | 0.6894 | 0.6789 | 0.0475 | 0.0471 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 622 | 28 | 0.5833 | 0.6789 | 0.0450 | 0.0471 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 1095 | 43 | 1.0331 | 0.7915 | 0.0393 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 854 | 49 | 0.7905 | 0.7915 | 0.0574 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 591 | 30 | 0.5509 | 0.7915 | 0.0508 | 0.0491 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 721 | 33 | 0.6756 | 0.8036 | 0.0458 | 0.0497 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 913 | 53 | 0.8445 | 0.8036 | 0.0581 | 0.0497 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 950 | 43 | 0.8907 | 0.8036 | 0.0453 | 0.0497 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 1 | 734 | 32 | 0.6894 | 0.8164 | 0.0436 | 0.0519 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 901 | 55 | 0.8308 | 0.8164 | 0.0610 | 0.0519 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 3 | 997 | 51 | 0.9290 | 0.8164 | 0.0512 | 0.0519 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 985 | 40 | 0.9280 | 0.7182 | 0.0406 | 0.0494 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 2 | 755 | 33 | 0.7090 | 0.7182 | 0.0437 | 0.0494 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 3 | 563 | 36 | 0.5175 | 0.7182 | 0.0639 | 0.0494 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 1 | 933 | 49 | 0.8681 | 0.6959 | 0.0525 | 0.0496 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 757 | 37 | 0.7070 | 0.6959 | 0.0489 | 0.0496 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 3 | 548 | 26 | 0.5126 | 0.6959 | 0.0474 | 0.0496 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 682 | 97 | 0.5745 | 0.6805 | 0.1422 | 0.1572 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 871 | 154 | 0.7041 | 0.6805 | 0.1768 | 0.1572 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 917 | 140 | 0.7630 | 0.6805 | 0.1527 | 0.1572 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 714 | 97 | 0.6059 | 0.6759 | 0.1359 | 0.1363 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 808 | 122 | 0.6736 | 0.6759 | 0.1510 | 0.1363 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 868 | 106 | 0.7483 | 0.6759 | 0.1221 | 0.1363 |